focus -WSS

focus

author：fashion 2025-10-01 10:48:08 Page View：5663

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cytokinetics CEO stresses company can launch heart drug on its own
Next article： Trump demands the U.S. pay no more for drugs than other countries … again

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Cytokinetics CEO stresses company can launch heart drug on its own

CytokineticsCEORobertBlumspokeThursdayatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Humana, CVS hope to turn members into patients at clinics

AdobeBothHumanaandCVSHealthonWednesdaytoutedplanstoaggressivelyscaletheirprimarycareclinicsforsenior

focus

explore

Wikipedia

Humana, CVS hope to turn members into patients at clinics